Free Trial

genedrive (GDR) Competitors

genedrive logo
GBX 1.43 +0.01 (+0.35%)
As of 08:27 AM Eastern

GDR vs. AGL, YGEN, ABDX, PRM, GENI, VRCI, DMTR, LLAI, LLA, and IDHC

Should you be buying genedrive stock or one of its competitors? The main competitors of genedrive include ANGLE (AGL), Yourgene Health (YGEN), Abingdon Health (ABDX), Proteome Sciences (PRM), GENinCode (GENI), Verici Dx (VRCI), Deepmatter Group (DMTR), LungLife AI (LLAI), LLA.L,0P0001T9GN,0 (LLA), and Integrated Diagnostics (IDHC). These companies are all part of the "diagnostics & research" industry.

genedrive vs. Its Competitors

ANGLE (LON:AGL) and genedrive (LON:GDR) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, dividends, earnings, media sentiment, valuation, risk, analyst recommendations and institutional ownership.

In the previous week, ANGLE's average media sentiment score of 0.00 equaled genedrive'saverage media sentiment score.

Company Overall Sentiment
ANGLE Neutral
genedrive Neutral

ANGLE currently has a consensus price target of GBX 40, indicating a potential upside of 515.38%. Given ANGLE's stronger consensus rating and higher possible upside, research analysts plainly believe ANGLE is more favorable than genedrive.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ANGLE
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
genedrive
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

genedrive has lower revenue, but higher earnings than ANGLE. ANGLE is trading at a lower price-to-earnings ratio than genedrive, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ANGLE£2.44M8.58-£21.76M-£6.76-0.96
genedrive£1.50M5.40-£21.22M-£3.57-0.40

18.8% of ANGLE shares are held by institutional investors. Comparatively, 0.3% of genedrive shares are held by institutional investors. 16.2% of ANGLE shares are held by company insiders. Comparatively, 14.8% of genedrive shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

ANGLE has a net margin of -890.91% compared to genedrive's net margin of -1,412.18%. ANGLE's return on equity of -76.01% beat genedrive's return on equity.

Company Net Margins Return on Equity Return on Assets
ANGLE-890.91% -76.01% -29.89%
genedrive -1,412.18%-191.22%-74.09%

ANGLE has a beta of 0.22, suggesting that its stock price is 78% less volatile than the S&P 500. Comparatively, genedrive has a beta of -0.04, suggesting that its stock price is 104% less volatile than the S&P 500.

Summary

ANGLE beats genedrive on 11 of the 14 factors compared between the two stocks.

Get genedrive News Delivered to You Automatically

Sign up to receive the latest news and ratings for GDR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GDR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GDR vs. The Competition

MetricgenedriveDiagnostics & Research IndustryMedical SectorLON Exchange
Market Cap£8.12M£769.72M£5.46B£2.97B
Dividend Yield1.57%5.44%5.24%5.02%
P/E Ratio-0.402.0927.07150.92
Price / Sales5.40498.16381.52244,729.07
Price / Cash2.0011.4226.2127.97
Price / Book0.512.768.014.57
Net Income-£21.22M£334.07B£3.17B£5.90B
7 Day Performance2.14%-1.14%3.53%1.43%
1 Month Performance-2.72%-4.40%2.73%4.67%
1 Year Performance-17.58%-8.38%34.10%79.82%

genedrive Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GDR
genedrive
N/AGBX 1.43
+0.4%
N/A-17.4%£8.12M£1.50M-0.4043Gap Up
AGL
ANGLE
1.79 of 5 stars
GBX 7.92
+5.7%
GBX 40
+404.8%
-55.9%£25.54M£2.44M-1.17650Gap Up
YGEN
Yourgene Health
N/AN/AN/AN/A£16.43M£29.67M-51.50253
ABDX
Abingdon Health
N/AGBX 6.52
-6.9%
N/A-36.2%£12.63M£3.84M-15.8584Gap Down
PRM
Proteome Sciences
N/AGBX 3.05
flat
N/AN/A£9.00M£10.88B-2.21240Gap Down
GENI
GENinCode
N/AGBX 2.50
+11.1%
N/A-71.1%£4.44M£2.67M-0.732,300Gap Down
VRCI
Verici Dx
N/AGBX 1.25
+11.1%
N/A-84.2%£3.79M£5.91M-0.7219Gap Up
DMTR
Deepmatter Group
N/AN/AN/AN/A£1.33M£1.04M-0.11N/AGap Down
LLAI
LungLife AI
N/AGBX 3.50
-17.6%
N/A-75.9%£1.16M£33.87K-0.2815Gap Down
High Trading Volume
LLA
LLA.L,0P0001T9GN,0
N/AN/AN/AN/A£0.00N/A-25.0015Gap Down
High Trading Volume
IDHC
Integrated Diagnostics
N/AGBX 0.36
+1.4%
N/A+12.5%£10.60B£23.29T13.386,692

Related Companies and Tools


This page (LON:GDR) was last updated on 7/8/2025 by MarketBeat.com Staff
From Our Partners